Author:
López-Pousa A,Losa R,Martín J,Maurel J,Fra J,Sierra M,Casado A,García del Muro J,Poveda A,Balañá C,Martínez-Trufero J,Esteban E,Buesa J M
Publisher
Springer Science and Business Media LLC
Reference32 articles.
1. Abbruzzese JL, Grunewald R, Weeks EA, Gravel D, Adams T, Nowak B, Mineishi S, Tarassoff P, Satterlee W, Raber MN (1991) A phase I clinical, plasma, and cellular pharmacology study of gemcitabine. J Clin Oncol 9: 491–498
2. Amodio A, Carpano S, Manfredi C, Del Monte G, Di Lauro L, Gionfra T, Conti F, Paoletti G, Lopez M (1999) Gemcitabine in advanced stage soft tissue sarcoma: a phase II study. Clin Ther 150: 17–20
3. Borden EC, Amato DA, Edmonson JH, Ritch PS, Shiraki M (1990) Randomized comparison of doxorubicin and vindesine to doxorubicin for patients with metastatic soft-tissue sarcomas. Cancer 66: 862–867
4. Brand R, Capadano M, Tempero M (1997) A phase I trial of weekly gemcitabine administered as a prolonged infusion in patients with pancreatic cancer and other solid tumors. Invest New Drugs 15: 331–341. DOI: 10.1023/A:100598117532
5. Brennan MF, Alektiar KM, Maki RG (2001) Sarcomas of the soft- tissue and bone. In Cancer: Principles and Practice of Oncology, DeVita VT, Hellman S, Rosenberg SA (eds) pp 1841–1891. Philadelphia: Lippincott Williams and Wilkins
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献